These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16997345)

  • 1. Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophages.
    Dou H; Morehead J; Destache CJ; Kingsley JD; Shlyakhtenko L; Zhou Y; Chaubal M; Werling J; Kipp J; Rabinow BE; Gendelman HE
    Virology; 2007 Feb; 358(1):148-58. PubMed ID: 16997345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus type 1 induces cellular polarization, intercellular adhesion molecule-1 redistribution, and multinucleated giant cell generation in human primary monocytes but not in monocyte-derived macrophages.
    Fais S; Borghi P; Gherardi G; Logozzi M; Belardelli F; Gessani S
    Lab Invest; 1996 Dec; 75(6):783-90. PubMed ID: 8973473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. If taken 1 hour before indinavir (IDV), didanosine does not affect IDV exposure, despite persistent buffering effects.
    Shelton MJ; Mei H; Hewitt RG; Defrancesco R
    Antimicrob Agents Chemother; 2001 Jan; 45(1):298-300. PubMed ID: 11120981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two immunomodulators, curcumin and sulfasalazine, enhance IDV antiretroviral activity in HIV-1 persistently infected cells.
    Riva DA; Fernández-Larrosa PN; Dolcini GL; Martínez-Peralta LA; Coulombié FC; Mersich SE
    Arch Virol; 2008; 153(3):561-5. PubMed ID: 18175040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stavudine-loaded mannosylated liposomes: in-vitro anti-HIV-I activity, tissue distribution and pharmacokinetics.
    Garg M; Asthana A; Agashe HB; Agrawal GP; Jain NK
    J Pharm Pharmacol; 2006 May; 58(5):605-16. PubMed ID: 16640829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4+ T lymphocytes.
    Pollicita M; Schols D; Aquaro S; Peumans WJ; Van Damme EJ; Perno CF; Balzarini J
    Virology; 2008 Jan; 370(2):382-91. PubMed ID: 17928023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS.
    Dou H; Grotepas CB; McMillan JM; Destache CJ; Chaubal M; Werling J; Kipp J; Rabinow B; Gendelman HE
    J Immunol; 2009 Jul; 183(1):661-9. PubMed ID: 19535632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo cytolysis and fusion of human immunodeficiency virus type 1-infected lymphocytes in lymphoid tissue.
    Orenstein JM
    J Infect Dis; 2000 Jul; 182(1):338-42. PubMed ID: 10882620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV antiretroviral drug combination induces endothelial mitochondrial dysfunction and reactive oxygen species production, but not apoptosis.
    Jiang B; Hebert VY; Li Y; Mathis JM; Alexander JS; Dugas TR
    Toxicol Appl Pharmacol; 2007 Oct; 224(1):60-71. PubMed ID: 17669453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis toxin and its binding unit inhibit HIV-1 infection of human cervical tissue and macrophages involving a CD14 pathway.
    Hu Q; Younson J; Griffin GE; Kelly C; Shattock RJ
    J Infect Dis; 2006 Dec; 194(11):1547-56. PubMed ID: 17083039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery.
    Dou H; Destache CJ; Morehead JR; Mosley RL; Boska MD; Kingsley J; Gorantla S; Poluektova L; Nelson JA; Chaubal M; Werling J; Kipp J; Rabinow BE; Gendelman HE
    Blood; 2006 Oct; 108(8):2827-35. PubMed ID: 16809617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir.
    Rossi L; Franchetti P; Pierigé F; Cappellacci L; Serafini S; Balestra E; Perno CF; Grifantini M; Caliò R; Magnani M
    J Antimicrob Chemother; 2007 Apr; 59(4):666-75. PubMed ID: 17327293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superiority of infectivity-based over particle-based methods for quantitation of drug resistant HIV-1 as inocula for cell cultures.
    Tschochner M; Schwingel E; Thein C; Wittmann S; Paatz C; Walter H
    J Virol Methods; 2007 Apr; 141(1):87-96. PubMed ID: 17196267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery.
    Nowacek AS; Miller RL; McMillan J; Kanmogne G; Kanmogne M; Mosley RL; Ma Z; Graham S; Chaubal M; Werling J; Rabinow B; Dou H; Gendelman HE
    Nanomedicine (Lond); 2009 Dec; 4(8):903-17. PubMed ID: 19958227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of indinavir used alone or in double or triple combination with AZT and ddC on human immune functions.
    Mattioli B; Giordani L; Quaranta MG; Viora M
    Life Sci; 2004 Mar; 74(18):2291-300. PubMed ID: 14987953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication of HIV-1 in vivo and in vitro.
    Orenstein JM
    Ultrastruct Pathol; 2007; 31(2):151-67. PubMed ID: 17613995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of stimulatory pathways on adipogenesis and HIV-therapy associated lipoatrophy.
    Stankov MV; Schmidt RE; Behrens GM
    Exp Biol Med (Maywood); 2009 Dec; 234(12):1484-92. PubMed ID: 19934369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. M1 and M2a polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms.
    Cassol E; Cassetta L; Rizzi C; Alfano M; Poli G
    J Immunol; 2009 May; 182(10):6237-46. PubMed ID: 19414777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-HIV-1 activity of the Iboga alkaloid congener 18-methoxycoronaridine.
    Silva EM; Cirne-Santos CC; Frugulhetti IC; Galvão-Castro B; Saraiva EM; Kuehne ME; Bou-Habib DC
    Planta Med; 2004 Sep; 70(9):808-12. PubMed ID: 15386189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dual chamber model of female cervical mucosa for the study of HIV transmission and for the evaluation of candidate HIV microbicides.
    Van Herrewege Y; Michiels J; Waeytens A; De Boeck G; Salden E; Heyndrickx L; van den Mooter G; de Béthune MP; Andries K; Lewi P; Praet M; Vanham G
    Antiviral Res; 2007 May; 74(2):111-24. PubMed ID: 17097156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.